Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011)

计划入组 103 人 · 首次发布于 2022 年 2 月 23 日

DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma

计划入组 292 人 · 首次发布于 2024 年 6 月 27 日

TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standard of Care

计划入组 10 人 · 首次发布于 2021 年 7 月 26 日

LUAA-399599

LEAD-462

LUAA-34893

Lund University Foundation

United States

Lund University Hospital

Sweden

LEAD CHEMICAL CO., LTD.

Japan

UBE2N Emerges as Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma

Circular eccDNA Features Offer New Prognostic Insights for Early-Stage Lung Adenocarcinoma Recurrence

ORACLE Signature Validated as Predictor of Lung Cancer Survival and Chemosensitivity